Nicolas Béry

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

15h-index1.4kcitations82works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(21), Epigenetics and DNA Methylation(20), Pancreatic and Hepatic Oncology Research(16), Adenosine and Purinergic Signaling(16), Ubiquitin and proteasome pathways(13)

Publications82 total

The TRIP12’s intrinsically disordered region induces chromatin condensates and interferes with nuclear processes
iScience·2026Open Access
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis
eLife·2025Open Access
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis
2025Open Access
Author response: Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis
2025Open Access
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis
eLife·2025Open Access
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis
2025Open Access
The Intrinsically Disordered Region of the E3 Ubiquitin Ligase TRIP12 Induces Chromatin Condensates Formation and Interferes with Nuclear Processes
SSRN Electronic Journal·2025Open Access
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis
2024Open Access
Targeting hard-to-drug proteins in cancer with potent intracellular biodegraders
SPIRE - Sciences Po Institutional REpository·2024
Protocol to identify E3 ligases amenable to biodegraders using a cell-based screening
STAR Protocols·2024Open Access
Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells
Communications Biology·2024· 7 citedOpen Access
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies
Nature Communications·2024· 14 citedOpen Access
TDP1 mutation causing SCAN1 neurodegenerative syndrome hampers the repair of transcriptional DNA double-strand breaks
Cell Reports·2024· 15 citedOpen Access
Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders
iScience·2024· 6 citedOpen Access
Data from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs
2024Open Access
Figure S4 from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs
2024Open Access
Figure S5 from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs
2024Open Access
Data from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs
2024Open Access
Figure S3 from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs
2024Open Access
Figure S2 from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs
2024Open Access
page 1 of 5Next →

Frequent Co-authors

Pierre Cordelier(16), Terence H. Rabbitts(15), Gilles Favre(12), Aurélien Olichon(11), Audrey Lumeau(10), Audrey Francès(10), Marion Gayral(10), Guillaume Labrousse(10), Nelson Dusetti(10), Ami Miller(9), Juan‐Pablo Cerapio(9), Cyril Ribeyre(9), Adèle Nevot(9), Naı̈ma Hanoun(9), Miguel Madrid-Mencía(9), Véra Pancaldi(9), Marie‐Jeanne Pillaire(9), Valérie Bergoglio(9), Jérôme Torrisani(9), Jean‐Sèbastien Hoffmann(9)